The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

One of the key findings in recent studies is the role of glucagon-like peptide-1 (GLP-1) in postprandial hypoglycemia. After bariatric surgery, the body often experiences an exaggerated release of ...

Manufactured by Novo Nordisk, semaglutide is the newest in a family of glucagon-like peptide-1 receptor agonists used most ..

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

The following is a summary of “Endoscopy and Anesthesia Outcomes Associated with Glucagon-Like Peptide-1 Receptor Agonist Use ...

The search for effective weight loss solutions has led to countless diet trends, fitness regimens, and medical interventions.

MBX Biosciences, Inc.’s MBX share price has dipped by 14.00%, which has investors questioning if this is right time to buy.

Glucagon-like peptide-1 receptor (GLP-1 ... Seth Kipnis, MD, medical director of bariatric and robotic surgery at Hackensack Meridian Jersey Shore University Medical Center, was not involved ...

A new study reports that GLP-1 medications may provide benefits ... medical director of Bariatric and Robotic Surgery at Hackensack Meridian Jersey Shore University Medical Center in New Jersey ...

Bariatric surgery is currently the most ... treatment of diabetes and obesity is currently limited. The glucagon-like peptide-1 receptor agonists improve glycemia and induce a modest weight ...